NCT02906384

Brief Summary

This is a prospective, randomized phase-II study observing the memory preservation and functional brain MRI changes with conformal avoidance of the hippocampal neural stem-cell compartment during prophylactic cranial irradiation for small cell lung cancer patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
154

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Oct 2016

Typical duration for phase_2

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 9, 2016

Completed
11 days until next milestone

First Posted

Study publicly available on registry

September 20, 2016

Completed
11 days until next milestone

Study Start

First participant enrolled

October 1, 2016

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2018

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2020

Completed
Last Updated

October 10, 2016

Status Verified

October 1, 2016

Enrollment Period

2 years

First QC Date

September 9, 2016

Last Update Submit

October 6, 2016

Conditions

Keywords

hippocampus avoidancevolumetric modulated arc therapyfunctional MRIhopkins Verbal Learning Testprophylactic cranial irradiation

Outcome Measures

Primary Outcomes (1)

  • memory preservation

    responses to Hopkins Verbal Learning Test

    2 years

Secondary Outcomes (3)

  • overall survival

    2 years

  • hippocampus metastasis

    2 years

  • image changes of brain

    2 years

Study Arms (2)

routine PCI

NO INTERVENTION

PTV:25Gy/10F. Radiation technique: VMAT.

HA-PCI

EXPERIMENTAL

PTV 25Gy/10F. Hippocampus avoidance: decrease the dose to HAZ as the following criteria: Dmin\<9Gy Dmax\<16Gy. Radiation technique: VMAT.

Radiation: hippocampus avoidance

Interventions

conformal avoidance of the hippocampal neural stem-cell compartment during prophylactic cranial irradiation

HA-PCI

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Histologically conformed small cell lung cancer;
  • Complete response (CR)/partial response (PR) after chemo-radiotherapy;
  • ECOG (Eastern Cooperative Oncology Group) : 0-1;
  • No imaging evidence of brain metastasis before PCI;
  • Normal hemodynamic indices before the recruitment (including white blood cell count\>4.0×109/L, neutrophil count\>1.5×109/L, platelet count \>100×109/L, hemoglobin≥90g/l, normal liver/kidney function);
  • Able to understand this study and have signed informed consent.

You may not qualify if:

  • Unable to receive MRI;
  • Medical history of central nervous system, cognitive or psychological diseases;
  • The expectation of life is less than 6 months;
  • Female in pregnancy or lactating;
  • The researchers consider the patient not appropriate to be enrolled.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zhejiang Cancer Hospital

Hangzhou, Zhejiang, 310022, China

RECRUITING

MeSH Terms

Conditions

Small Cell Lung Carcinoma

Condition Hierarchy (Ancestors)

Carcinoma, BronchogenicBronchial NeoplasmsLung NeoplasmsRespiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Ming Chen, PHD

    Zhejiang Cancer Hospital

    PRINCIPAL INVESTIGATOR
  • Yue Kong

    Zhejiang Cancer Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 9, 2016

First Posted

September 20, 2016

Study Start

October 1, 2016

Primary Completion

October 1, 2018

Study Completion

October 1, 2020

Last Updated

October 10, 2016

Record last verified: 2016-10

Data Sharing

IPD Sharing
Will not share

Locations